SESAME technique: septal scoring along the midline endocardium
Our study corroborates the feasibility and efficacy of SESAME for prohibitive surgical risk patients needing septal reduction therapy prior to TMVR or for treatment of oHCM or a subaortic membrane.
Authors
- Gregory Condos (ORCID: https://orcid.org/0000-0002-8958-1897)
- Vasilis Babaliaros (ORCID: https://orcid.org/0000-0002-9438-0846)
- Adam B. Greenbaum (ORCID: https://orcid.org/0000-0001-7496-5954)
- Ester Cánovas
- Robert J. Lederman (ORCID: https://orcid.org/0000-0003-1202-6673)
- David Elison (ORCID: https://orcid.org/0000-0002-9367-2724)
- Barbara A. Danek (ORCID: https://orcid.org/0000-0002-7607-4204)
- Srdjan Jelačić (ORCID: https://orcid.org/0000-0002-6617-9870)
- Christine J Chung (ORCID: https://orcid.org/0000-0001-6762-5417)
- Richard Sheu (ORCID: https://orcid.org/0000-0003-0198-012X)
- G Burkhard Mackensen
- Shauna L. Newton
- James M. McCabe (ORCID: https://orcid.org/0000-0003-0452-2327)
Institutions
- Naval Medical Center San Diego (US)
- University of Washington (US)
- Emory University Hospital (US)
Publication Details
- Journal
- EuroIntervention
- Published
- 2025-08-01
- DOI
- https://doi.org/10.4244/eij-d-25-00131
- Citations
- 2
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.78